🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jonathan W. Goldman

Santa Monica College

ORCID: 0000-0002-4925-8243

Also affiliated with University of California, Los Angeles, University of Colorado Cancer Center, UCLA Jonsson Comprehensive Cancer Center, University of Colorado Denver

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial”.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Annals of Oncology(2023)10.1016/j.annonc.2023.08.003

N/A

1.4DataRank · unranked

61 citations

L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

Molecular Cancer(2024)10.1186/s12943-024-02014-x

N/A

0.975DataRank · unranked

43 citations

Miljenka Vuko, Jaime Rodriguez‐Canales, Johannes Zimmermann, Markus Schick, Cathy O’Brien +13 more

TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11 -Mutant Tumors to Anti–PD-1 Immunotherapy

Cancer Research(2025)10.1158/0008-5472.can-25-0998

N/A

0.104DataRank · unranked

1 citations

Soumyadip Sahu, Minjie Zhang, Ayushi S. Patel, Ke Geng, Reshmee Bhattacharya +47 more

The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100427

N/A

0DataRank · unranked

12 citations

Shuai Chen, Joanna B. Eldredge, Shiruyeh Schokrpur, Debory Li, Zhikuan Quan +11 more

Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer

Frontiers in Oncology(2023)10.3389/fonc.2023.1178313

N/A

0DataRank · unranked

9 citations

Lynette M. Sholl, Sanja Đačić, Michael C. Fishbein, Yonina R. Murciano‐Goroff, Ravi Rajaram +5 more

Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100468

N/A

0DataRank · unranked

9 citations

Michael Xiang, Stephanie Yoon, Alan Lee, Dan Ruan, Jonathan W. Goldman +5 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0DataRank · unranked

165 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.12.003

N/A

0DataRank · unranked

4 citations

A. Martinez Bueno, Christophe Dooms, Komal Jhaveri, Maria de Miguel, Sarina A. Piha‐Paul +12 more

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

Nature Communications(2025)10.1038/s41467-025-61817-8

N/A

0DataRank · unranked

7 citations

Jacqulyne Robichaux, Monique B. Nilsson, R. S. K. Vijayan, Ashwin Ravichandran, Jia Wu +21 more

Circulating tumor DNA (ctDNA) mutations may predict treatment response in extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib and temozolomide (TMZ).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8564

N/A

0DataRank · unranked

2 citations

Amy L. Cummings, Melody Mendenhall, David E. Kanamori, Andrew Nguyen, David Dae-Young Kim +12 more

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1386

N/A

0DataRank · unranked

29 citations

Aaron Lisberg, Alejandro J. Garcia, Samuel Granjeaud, Anne Madroszyk, Stéphane Fattori +13 more